title: Comparison of a fractional microplasma radio frequency technology and carbon dioxide fractional laser for the treatment of atrophic acne scars: a randomized split-face clinical study.
abstract: BACKGROUND
  No studies have compared fractional microplasma radio frequency (RF) technology with the carbon dioxide fractional laser system (CO2 FS) in the treatment of atrophic acne scars in the same patient.
  
  
  OBJECTIVE
  To compare the efficacy and safety of fractional microplasma RF with CO2 FS in the treatment of atrophic acne scars.
  
  
  METHODS
  Thirty-three Asian patients received three sessions of a randomized split-face treatment of fractional microplasma RF or CO2 FS.
  
  
  RESULTS
  Both modalities had a roughly equivalent effect. Échelle d'Évaluation Clinique Des Cicatrices d'Acné scores were significantly lower after fractional microplasma RF (from 51.1 ± 14.2 to 22.3 ± 8.6, 56.4% improvement) and CO2 FS (from 48.8 ± 15.1 to 19.9 ± 7.9, 59.2% improvement) treatments. There was no statistically significant difference between the two therapies. Twelve subjects (36.4%) experienced postinflammatory hyperpigmentation (PIH) after 30 of 99 treatment sessions (30.3%) on the CO2 FS side and no PIH was observed on the fractional microplasma RF sides.
  
  
  CONCLUSIONS
  Both modalities have good effects on treating atrophic scars. PIH was not seen with the fractional microplasma RF, which might make it a better choice for patients with darker skin.
authors: Department of Dermatology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
authors: Zhen
authors: Z
authors: Zhang
authors: Ye
authors: Y
authors: Fei
authors: Xiangdong
authors: X
authors: Chen
authors: Wenli
authors: W
authors: Lu
authors: Jinan
authors: J
authors: Chen
mesh_terms: D000152:Acne Vulgaris / Q000150:complications*; D000293:Adolescent; D001284:Atrophy; D002921:Cicatrix / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D054020:Lasers, Gas / Q000009:adverse effects / Q000627:therapeutic use*; D028022:Low-Level Light Therapy; D008297:Male; D017060:Patient Satisfaction; D011846:Radio Waves / Q000009:adverse effects; D055815:Young Adult